Skip to ContentSkip to Navigation
How to find us dr. E. Meijer

Research interests

Esther Meijer is an internist-nephrologist with specific interest in Autosomal Dominant Polycystic Kidney Disease (ADPKD). At the University Medical Center Groningen (UMCG), she combines clinical work with research. She sees approximately 250 ADPKD patients per year and is study coordinator of a Dutch national observational cohort of ADPKD patients. Her current research focuses on markers of disease progression, and improving treatment in ADPKD. In 2019, she received an early career grant from the Dutch Kidney Foundation to investigate improvement of treatment with a vasopressin V2 receptor antagonist, by decreasing the adverse events. 

Publications

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients

Author's Reply to Correspondence: "Effect of Tolvaptan Treatment on Acid-Base Homeostasis in ADPKD Patients"

Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice

Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression

No Change in Nocturia After NOCTURNE

Polycystic Kidney Disease Caused by Bilineal Inheritance of Truncating PKD1 as Well as PKD2 Mutations

Salt, but not protein intake, is associated with accelerated disease progression in autosomal dominant polycystic kidney disease

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease

Thiazide diuretics and the rate of disease progression in autosomal dominant polycystic kidney disease: an observational study

Read more